Evidence map›Paper›PMID 29162697›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

EB1-binding-myomegalin protein complex promotes centrosomal microtubules functions.

Habib Bouguenina, Danièle Salaun, Aurélie Mangon, Leslie Muller, Emilie Baudelet, Luc Camoin, Taro Tachibana, Sarah Cianférani, Stéphane Audebert, Pascal Verdier-Pinard and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. PDE4DIP in health and diseases.Cellular signalling · 2022
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. AKAP Signaling Islands: Venues for Precision Pharmacology.Trends in pharmacological sciences · 2020
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Habib BougueninaCentre de Recherche en Cancérologie de Marseille (CRCM), INSERM, Institut Paoli-Calmettes, CNRS, Aix-Marseille Université,13009 Marseille, France.
Danièle SalaunCentre de Recherche en Cancérologie de Marseille (CRCM), INSERM, Institut Paoli-Calmettes, CNRS, Aix-Marseille Université,13009 Marseille, France.
Aurélie MangonCentre de Recherche en Cancérologie de Marseille (CRCM), INSERM, Institut Paoli-Calmettes, CNRS, Aix-Marseille Université,13009 Marseille, France.
Leslie MullerLaboratoire de Spectrométrie de Masse BioOrganique, CNRS, Institut Pluridisciplinaire Hubert Curien UMR 7178, Université de Strasbourg, 67087 Strasbourg, France.
Emilie BaudeletCentre de Recherche en Cancérologie de Marseille (CRCM), INSERM, Institut Paoli-Calmettes, CNRS, Aix-Marseille Université,13009 Marseille, France.
Luc CamoinCentre de Recherche en Cancérologie de Marseille (CRCM), INSERM, Institut Paoli-Calmettes, CNRS, Aix-Marseille Université,13009 Marseille, France.
Taro TachibanaDepartment of Bioengineering, Graduate School of Engineering, Osaka City University, Osaka 558-8585, Japan.
Sarah CianféraniLaboratoire de Spectrométrie de Masse BioOrganique, CNRS, Institut Pluridisciplinaire Hubert Curien UMR 7178, Université de Strasbourg, 67087 Strasbourg, France.
Stéphane AudebertCentre de Recherche en Cancérologie de Marseille (CRCM), INSERM, Institut Paoli-Calmettes, CNRS, Aix-Marseille Université,13009 Marseille, France.ORCID 0000-0002-9409-2588
Pascal Verdier-PinardCentre de Recherche en Cancérologie de Marseille (CRCM), INSERM, Institut Paoli-Calmettes, CNRS, Aix-Marseille Université,13009 Marseille, France; pascal.verdier-pinard@inserm.fr ali.badache@inserm.fr.
Ali BadacheCentre de Recherche en Cancérologie de Marseille (CRCM), INSERM, Institut Paoli-Calmettes, CNRS, Aix-Marseille Université,13009 Marseille, France; pascal.verdier-pinard@inserm.fr ali.badache@inserm.fr.ORCID 0000-0001-7710-2505
Centre National de la Recherche Scientifique · FROsaka City University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Control of microtubule dynamics underlies several fundamental processes such as cell polarity, cell division, and cell motility. To gain insights into the mechanisms that control microtubule dynamics during cell motility, we investigated the interactome of the microtubule plus-end-binding protein end-binding 1 (EB1). Via molecular mapping and cross-linking mass spectrometry we identified and characterized a large complex associating a specific isoform of myomegalin termed "SMYLE" (for short myomegalin-like EB1 binding protein), the PKA scaffolding protein AKAP9, and the pericentrosomal protein CDK5RAP2. SMYLE was associated through an evolutionarily conserved N-terminal domain with AKAP9, which in turn was anchored at the centrosome via CDK5RAP2. SMYLE connected the pericentrosomal complex to the microtubule-nucleating complex (γ-TuRC) via Galectin-3-binding protein. SMYLE associated with nascent centrosomal microtubules to promote microtubule assembly and acetylation. Disruption of SMYLE interaction with EB1 or AKAP9 prevented microtubule nucleation and their stabilization at the leading edge of migrating cells. In addition, SMYLE depletion led to defective astral microtubules and abnormal orientation of the mitotic spindle and triggered G1 cell-cycle arrest, which might be due to defective centrosome integrity. As a consequence, SMYLE loss of function had a profound impact on tumor cell motility and proliferation, suggesting that SMYLE might be an important player in tumor progression.

Indexed as

Adaptor Proteins, Signal TransducingA Kinase Anchor ProteinsBinding SitesCell Cycle ProteinsCell ProliferationCentrosomeCytoskeletal ProteinsG1 Phase Cell Cycle CheckpointsHEK293 CellsHeLa CellsHumansIntracellular Signaling Peptides and ProteinsMicrotubule-Associated ProteinsMicrotubulesMuscle ProteinsNerve Tissue ProteinsAdaptor Proteins, Signal TransducingAKAP9 protein, humanA Kinase Anchor ProteinsCDK5RAP2 protein, humanCell Cycle ProteinsCytoskeletal ProteinsIntracellular Signaling Peptides and ProteinsMAPRE1 protein, humanMicrotubule-Associated ProteinsMuscle ProteinsNerve Tissue ProteinsNuclear ProteinsPDE4DIP protein, humanProtein Isoformscell motilitycentrosomemicrotubulesmitotic spindle

Identifiers

PMID29162697
PMCPMC5740655
OpenAlexW2769819317

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.